At 48 hpi, enrichment was noted in the TGF-beta signaling pathway, transcriptional misregulation in cancer, microRNAs in cancer, small cell lung cancer, and the p53 signaling pathway (Figure 2—figure supplement 1F). This evidence concerns the gene TP53 and small cell lung carcinoma.